Other · GlaxoSmithKline Pharmaceuticals Ltd
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE filed 8 Nov 2026, 1:42 pm IST
GlaxoSmithKline Pharmaceuticals Ltd closed at ₹2,524.80 +0.98% on 6 Nov.
What the filing saysQuoted from the document. Each line opens the page it is on.
- Outcome of Schedule of Analyst / Institutional Investor Meetings
Summary
A one-line summary, the filing chain and past follow-through are in Pro. The quoted passages above stay free. Compare plans
GlaxoSmithKline Pharmaceuticals Ltd’s recent filings
Sign up free to see GlaxoSmithKline Pharmaceuticals Ltd’s recent filings and follow the company.